“…[1][2][3][4] Factors contributing to unfavorable PKP outcomes included recurrent herpetic keratouveitis, neurotrophic complications (epitheliopathy, recurrent erosions, persistent epithelial defects, sterile corneal ulceration, or secondary microbial keratitis), iatrogenic ocular surface complications related to topical antiviral treatment and prophylaxis, glaucoma escalation, and immune-mediate endothelial rejection. [1][2][3][4] The introduction of systemic antiviral therapy dramatically reduced the incidence of recurrent herpetic keratouveitis after keratoplasty, as well as iatrogenic complications related to chronic use of prophylactic topical antiviral therapy. 4 This resulted in an improvement in the PKP prognosis in eyes with HSV, but not in those with HZV keratopathy, presumably because of the greater neurotrophic deficit and related complications associated with the latter condition.…”